Developing More Predictive In Vitro Models 3rd Annual Summit

Cutting Edge Advancements in In Vitro Models to Mitigate Toxicity, Streamline Drug Development and Direct Clinical Strategy
25 – 27 September 2012 | Boston
.

Andre Levchenko

Andre Levchenko:

Prof. Levchenko got his B. S. and M.S. degrees at the Moscow Institute of Science and Technology, frequently referred to us as the Russian Caltech. He then crossed the Pond to study at Columbia University, culminating in a PhD in Bioengineering. He simultaneously worked at the Memorial Sloan-Kettering Cancer Center on problems of cancer drug resistance. As a post-doctoral scholar at Caltech, he worked with faculty in Biology and Computer Science on understanding cell signaling in changing environments. Dr. Levchenko was then appointed to a faculty position at Johns Hopkins where he works on various problems related to cell decision making.